We are live on ! Find out more
EVM

Eaton Vance Management Portfolio holdings

AUM $67.5B
1-Year Est. Return 11.44%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
-11.44%
3 Year Est. Return
+49.6%
5 Year Est. Return
+94.25%
10 Year Est. Return
AUM
$51.1B
AUM Growth
+$4.49B
Cap. Flow
+$466M
Cap. Flow %
0.91%
Top 10 Hldgs %
22.4%
Holding
1,341
New
53
Increased
619
Reduced
410
Closed
27

Sector Composition

Rank Sector Weight
1 Technology 18.69%
2 Financials 16.15%
3 Healthcare 14.78%
4 Consumer Discretionary 11.33%
5 Communication Services 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICUI icon
276
ICU Medical
ICUI
$4.21B
$28.4M 0.06%
151,625
+21,070
+16% +$3.63M
TXRH icon
277
Texas Roadhouse
TXRH
$13.5B
$28.3M 0.06%
502,175
PCAR icon
278
PACCAR
PCAR
$69.8B
$27.8M 0.05%
526,797
-801
-0.2% -$41.2K
PXD
279
DELISTED
Pioneer Natural Resource Co.
PXD
$27.8M 0.05%
184,480
-29,358
-14% -$3.91M
TW icon
280
Tradeweb Markets
TW
$21.4B
$27.6M 0.05%
596,207
+302,236
+103% +$13M
NVS icon
281
Novartis
NVS
$297B
$27.4M 0.05%
289,457
+4,555
+2% +$409K
BF.B icon
282
Brown-Forman Class B
BF.B
$13.2B
$27M 0.05%
399,497
-80,236
-17% -$5.21M
IART icon
283
Integra LifeSciences
IART
$1.29B
$26.7M 0.05%
458,877
+253,545
+123% +$15.1M
CBU icon
284
Community Bank
CBU
$3.41B
$26.4M 0.05%
371,602
+59,283
+19% +$3.97M
EGP icon
285
EastGroup Properties
EGP
$11.2B
$26.2M 0.05%
197,577
+1,873
+1% +$246K
VCSH icon
286
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$25.9M 0.05%
320,082
+4,825
+2% +$391K
EBS icon
287
Emergent Biosolutions
EBS
$373M
$25.9M 0.05%
480,684
+286,263
+147% +$15.5M
P
288
Everpure Inc
P
$25.7B
$25.8M 0.05%
1,508,241
ALNY icon
289
Alnylam Pharmaceuticals
ALNY
$27.5B
$25.4M 0.05%
220,580
-24
-0% -$2.39K
LHX icon
290
L3Harris
LHX
$51.6B
$25.4M 0.05%
128,247
+11,000
+9% +$2.21M
BKI
291
DELISTED
Black Knight, Inc. Common Stock
BKI
$25.3M 0.05%
392,679
+4,236
+1% +$262K
CBZ icon
292
CBIZ
CBZ
$2.99B
$25.3M 0.05%
938,525
+377,710
+67% +$9.83M
EGOV
293
DELISTED
NIC Inc
EGOV
$25.3M 0.05%
1,131,061
+251,794
+29% +$5.51M
OKTA icon
294
Okta
OKTA
$24.7B
$25.1M 0.05%
217,624
-11,835
-5% -$1.36M
MCK icon
295
McKesson
MCK
$100B
$25.1M 0.05%
181,501
+145,996
+411% +$20.6M
FCNCA icon
296
First Citizens BancShares
FCNCA
$24.9B
$25.1M 0.05%
47,093
+7,804
+20% +$3.95M
TREX icon
297
Trex
TREX
$4.51B
$25M 0.05%
555,404
+16,032
+3% +$706K
RF icon
298
Regions Financial
RF
$26.4B
$24.9M 0.05%
1,451,209
+17,956
+1% +$296K
IDXX icon
299
Idexx Laboratories
IDXX
$44.1B
$24.8M 0.05%
94,920
+7,963
+9% +$2.1M
SPY icon
300
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$24.6M 0.05%
76,496
-2,323
-3% -$715K

Similar funds

Eaton Vance Management's Q4 2019 Portfolio in Review

As of Q4 2019, Eaton Vance Management held 1,341 positions worth $51.1B, up 9.6% from $46.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Eaton Vance Management's Q4 2019 filing shows 53 new, 619 increased, 410 reduced and 27 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 807,847 shares worth $71M. The largest sale was Procter & Gamble, an estimated $84.6M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Eaton Vance Management's largest Q4 2019 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 807,847 shares worth $71M.
  • Eaton Vance Management added most to State Street Blackstone Senior Loan ETF in Q4 2019, an estimated $203M increase.
  • Eaton Vance Management's biggest Q4 2019 reduction was Procter & Gamble, cutting an estimated $84.6M.
  • Eaton Vance Management fully exited Celgene Corp in Q4 2019, selling an estimated $79.7M.
  • Eaton Vance Management's ten largest holdings make up 22% of its $51.1B portfolio in Q4 2019.
  • Eaton Vance Management opened 53 new positions and closed 27 in Q4 2019.
  • Eaton Vance Management's portfolio value rose 9.6% quarter-over-quarter to $51.1B.

Based on Eaton Vance Management's 13F filing for Q4 2019, filed 11 Feb 2020.